SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Oliver & Co who wrote (2770)11/13/1997 9:06:00 PM
From: lizard lick  Respond to of 6136
 
tom i dont know if your still on this board but read the press release
that came out today on PCIT, point of care technologies, remember that one?, well they got FDA approval today and are shipping tommorrow, its going to be in every freaking doctors office and lawenforcement agency in the states, they are also have full patents on it for europe also, congratulations explosion finally here, next week is going to be great once news disseminatest, looks like that brokers target of 16 by january is right on, picked up a load in the 2's today------the release is on yahoo now, talk to you later

once again good call and congrats



To: Oliver & Co who wrote (2770)11/13/1997 9:34:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 6136
 
JLL, I don't read all of the posts on this thread. When I saw the news about the viral resiviore, I quickly skimmed to see if it had been posted. In Oct, when I posted about resistance, John W. seemed to think that PI's could eradicate the virus based on a mathematical model. I thought that the model of Dr. Ho was overly optimistic. The Science publications this week verify that such a model may work on paper, but not in human lymphocytes.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News